Rethinking global digital health and AI-for-health innovation challenges.

Digital health technologies can help tackle challenges in global public health. Digital and AI-for-Health Challenges, controlled events whose goal is to generate solutions to a given problem in a defined period of time, are one way of catalysing innovation. This article proposes an expanded investment framework for Global Health AI and digitalhealth Innovation that goes beyond traditional factors such as return on investment. Instead, we propose non monetary and non GDP metrics, such as Disability Adjusted Life Years or achievement of universal health coverage. Furthermore, we suggest a venture building approach around global health, which includes filtering of participants to reduce opportunity cost, close integration of implementation scientists and an incubator for the long-term development of ideas resulting from the challenge. Finally, we emphasize the need to strengthen human capital across a range of areas in local innovation, implementation-science, and in health services.

Ascertaining the optimal myoelectric signal recording duration for pattern recognition based prostheses control.

Introduction: Electromyogram-based pattern recognition (EMG-PR) has been widely considered an essentially intuitive control method for multifunctional upper limb prostheses. A crucial aspect of the scheme is the EMG signal recording duration (SRD) from which requisite motor tasks are characterized per time, impacting the system's overall performance. For instance, lengthy SRD inevitably introduces fatigue (that alters the muscle contraction patterns of specific limb motions) and may incur high computational costs in building the motion intent decoder, resulting in inadequate prosthetic control and controller delay in practical usage. Conversely, relatively shorter SRD may lead to reduced data collection durations that, among other advantages, allow for more convenient prosthesis recalibration protocols. Therefore, determining the optimal SRD required to characterize limb motion intents adequately that will aid intuitive PR-based control remains an open research question. Method: This study systematically investigated the impact and generalizability of varying lengths of myoelectric SRD on the characterization of multiple classes of finger gestures. The investigation involved characterizing fifteen classes of finger gestures performed by eight normally limb subjects using various groups of EMG SRD including 1, 5, 10, 15, and 20 s. Two different training strategies including Between SRD and Within-SRD were implemented across three popular machine learning classifiers and three time-domain features to investigate the impact of SRD on EMG-PR motion intent decoder. Result: The between-SRD strategy results which is a reflection of the practical scenario showed that an SRD greater than 5 s but less than or equal to 10 s (>5 and < = 10 s) would be required to achieve decent average finger gesture decoding accuracy for all feature-classifier combinations. Notably, lengthier SRD would incur more acquisition and implementation time and vice-versa. In inclusion, the study's findings provide insight and guidance into selecting appropriate SRD that would aid inadequate characterization of multiple classes of limb motion tasks in PR-based control schemes for multifunctional prostheses.

Towards image-based cancer cell lines authentication using deep neural networks.

Although short tandem repeat (STR) analysis is available as a reliable method for the determination of the genetic origin of cell lines, the occurrence of misauthenticated cell lines remains an important issue. Reasons include the cost, effort and time associated with STR analysis. Moreover, there are currently no methods for the discrimination between isogenic cell lines (cell lines of the same genetic origin, e.g. different cell lines derived from the same organism, clonal sublines, sublines adapted to grow under certain conditions). Hence, additional complementary, ideally low-cost and low-effort methods are required that enable (1) the monitoring of cell line identity as part of the daily laboratory routine and 2) the authentication of isogenic cell lines. In this research, we automate the process of cell line identification by image-based analysis using deep convolutional neural networks. Two different convolutional neural networks models (MobileNet and InceptionResNet V2) were trained to automatically identify four parental cancer cell line (COLO 704, EFO-21, EFO-27 and UKF-NB-3) and their sublines adapted to the anti-cancer drugs cisplatin (COLO-704rCDDP1000, EFO-21rCDDP2000, EFO-27rCDDP2000) or oxaliplatin (UKF-NB-3rOXALI2000), hence resulting in an eight-class problem. Our best performing model, InceptionResNet V2, achieved an average of 0.91 F1-score on tenfold cross validation with an average area under the curve (AUC) of 0.95, for the 8-class problem. Our best model also achieved an average F1-score of 0.94 and 0.96 on the authentication through a classification process of the four parental cell lines and the respective drug-adapted cells, respectively, on a four-class problem separately. These findings provide the basis for further development of the application of deep learning for the automation of cell line authentication into a readily available easy-to-use methodology that enables routine monitoring of the identity of cell lines including isogenic cell lines. It should be noted that, this is just a proof of principal that, images can also be used as a method for authentication of cancer cell lines and not a replacement for the STR method.